Loading

logo

Journal of Surgery and Surgical Reports

ISSN: 2837-8482

Short Communication Open Access

Coarctation of the aorta: Advances in diagnosis and management of a persistent congenital challenge

Suraj Pai1,*, Suresh Pai1, Meera Khadilkar2, Abhishar Sharma3
  • 1Department of Cardiovascular and Thoracic Surgery, Kasturba Medical College Mangalore, Manipal Academy of Higher Education, Manipal, India
  • 2Department of Otorhinolaryngology, Head and Neck Surgery, Kasturba Medical College Mangalore, Manipal Academy of Higher Education, Manipal, India
  • 3Department of General Surgery, Kasturba Medical College Mangalore, Manipal Academy of Higher Education, Manipal, Indian
+ Affiliations - Affiliations

Corresponding Author

Suraj Pai, drpaisuraj@gmail.com

Received Date: August 02, 2025

Accepted Date: December 12, 2025

Citation:

Pai S, Pai S, Khadilkar MN, Sharma A. Coarctation of the aorta: Advances in diagnosis and management of a persistent congenital challenge. J Surg Surg Rep. 2025;2(1):22-25.


Copyright: © 2025 Pai S, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Abstract

Coarctation of the aorta (CoA) is a congenital narrowing of the thoracic aorta, most often at the isthmus near the ductus arteriosus. It accounts for 5–8% of congenital heart defects and can present at any age. While early diagnosis in infancy is ideal, delayed presentations in adolescence or adulthood remain significant. Contemporary diagnostic tools—including echocardiography, CT angiography, and MRI—enable accurate anatomic assessment. Management has evolved from open surgery to include catheter-based interventions, especially in older children and adults. Lifelong follow-up is essential due to risks of restenosis, hypertension, and aortic aneurysm formation. This communication outlines key aspects of CoA diagnosis, treatment, and follow-up, with reference to current guidelines and literature.

Keywords

Coarctation of the aorta, Congenital heart disease, Aortic narrowing, Balloon angioplasty, Aortic stenting, Hypertension

Recommended Articles

Therapeutic antibody approach for pulmonary arterial hypertension

GMA301 is a novel antagonistic antibody in clinical development. GMA301 targets human endothelin receptor A (ETA), a proven therapeutic target for pulmonary arterial hypertension (PAH).

Fumarate hydratase as a potential target to ameliorate salt sensitive hypertension

Salt sensitive hypertension is a major risk factor for stroke, heart failure, and end-stage renal disease [1]. The development of salt sensitive hypertension is involved in genetic and environmental factors. Excessive dietary salt intake is known as a main risk factor and one of the most important environmental determinants, exacerbates the salt sensitive hypertension by a renal redox metabolism [2,3].

Knowledge, attitude and practice of life style modification in the management of hypertension

Hypertension remains as one of the most important public health challenges worldwide because of the associated morbidity, mortality, and the cost to the society. Despite the availability of safe and effective antihypertensive medications and the existence of clear treatment guidelines, hypertension is still inadequately controlled in a large proportion of patients worldwide. Unawareness of lifestyle modifications, and failure to apply these were one of the identified patient-related barriers to blood pressure control.

Full Text
Cite
Download PDF
Author Information X